SCHEMBL19631280

SCHEMBL19631280

Fc1ccc(F)c(/C=N/S)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 7/20 0.48
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39
GRIN1 Q05586 2/20 0.39
GRIN2A Q12879 2/20 0.39
GRIN2B Q13224 2/20 0.39
GRIN2C Q14957 2/20 0.39
GRIN3A Q8TCU5 2/20 0.39
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
RAB9A P51151 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1968882 0.78 NFE2L2 (0.48) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2924111 0.78 NFE2L2 (0.48) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1968880 0.78 NFE2L2 (0.48) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17526396 0.78 NFE2L2 (0.48) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL28115149 0.77 NFE2L2 (0.47) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11406890 0.75 NFE2L2 (0.50) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11406887 0.75 NFE2L2 (0.50) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL5252638 0.74 NFE2L2 (0.58) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL24080974 0.74 NFE2L2 (0.44) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13128154 0.74 NFE2L2 (0.47) NFE2L2GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3800189-B1 PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE LOXO ONCOLOGY INC (US) 2023-06-28 EP disclosed
WO-2020135203-A1 PHARMACEUTICAL COMPOUND, COMPOSITION THEREOF, AND APPLICATION 上海度德医药科技有限公司 2020-07-02 WO disclosed
WO-2017201241-A1 PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-Y L)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE REYNOLDS MARK (US) 2017-11-23 WO disclosed